Burning Rock Biotech Ltd (BNR) stock
BNRNasdaqServices-Medical Laboratories
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 28, 2026Score 4/30
$12.50−0.24 (-1.88%)
Close on Nov 17, 2026Market cap $136.07MP/E –Yield –
Burning Rock Biotech ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
For fiscal 2025 it was -CN¥33.08M. The highest annual figure on record is -CN¥33.08M in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -CN¥33.08M | – |
| FY2024 | Dec 31, 2024 | -CN¥305.36M | – |
| FY2023 | Dec 31, 2023 | -CN¥535.92M | – |
| FY2022 | Dec 31, 2022 | -CN¥856.31M | – |
| FY2021 | Dec 31, 2021 | -CN¥749.30M | – |
| FY2020 | Dec 31, 2020 | -CN¥379.10M | – |
| FY2019 | Dec 31, 2019 | -CN¥137.73M | – |
| FY2018 | Dec 31, 2018 | -CN¥136.72M | – |
See a number that looks wrong?